Eradivir - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeEradivir
Eradivir logo

Eradivir

0 followers

About Eradivir

Eradivir is a biotechnology company developing drugs that bind to diseased cells, guiding the immune system to fight disease. Their lead molecule, EV25, is a small molecule based Bispecific Antigenic immuno-Therapy (BAiT) technology that targets influenza and other diseases.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

West Lafayette, United States

Founded

2020

Employees

11 - 50

Status

Private

Website

https://eradivir.com